Brochure | June 28, 2022

FINIA® Fill and Finish System

Source: Terumo BCT

By the time you’ve reached the fill and finish step, you’ve invested a great deal. To fail now would result in a significant loss of time, resources and ultimately a final therapy to a patient.

Reduce these risks associated with a manual fill and finish process:*

  • Loss of cell viability
  • Operator-related product variability
  • Manual process and documentation fatigue
  • Contamination due to open events

Bring precision to your fill and finish step with the automated, functionally closed Finia:

  • Maintain > 90% post-thaw cell viability*
  • Produce precise and reproducible results
  • Facilitate current Good Manufacturing Practices (cGMP)
  • Enable the ability to scale with a fully automated system
access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene